Abstract: This disclosure describes techniques for configuring an IMD into the exposure operating mode. Prior to a medical procedure that generates a disruptive energy field, such as an MRI scan, an electronic prescription is configured to indicate that the IMD is authorized for the medical procedure that includes a disruptive energy field. The electronic prescription includes one or more designated bits within a storage element of the IMD. When the patient in which the IMD is implanted arrives for the medical procedure, a user (such as an MRI operator) interacts with a telemetry device to determine whether the electronic prescription is configured. Upon determining that the electronic prescription is configured, the IMD transitions into the exposure operating mode designed for operation in the disruptive energy field. In this manner, the electronic prescription confirms to the user that that the IMD has been checked for suitability for operation during the medical procedure.

Abstract: Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold.

Abstract: Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold.

Abstract: This disclosure describes techniques for configuring an IMD into the exposure operating mode. Prior to a medical procedure that generates a disruptive energy field, such as an MRI scan, an electronic prescription is configured to indicate that the IMD is authorized for the medical procedure that includes a disruptive energy field. The electronic prescription includes one or more designated bits within a storage element of the IMD. When the patient in which the IMD is implanted arrives for the medical procedure, a user (such as an MRI operator) interacts with a telemetry device to determine whether the electronic prescription is configured. Upon determining that the electronic prescription is configured, the IMD transitions into the exposure operating mode designed for operation in the disruptive energy field. In this manner, the electronic prescription confirms to the user that that the IMD has been checked for suitability for operation during the medical procedure.

Abstract: This disclosure describes techniques for configuring an IMD into the exposure operating mode. Prior to a medical procedure that generates a disruptive energy field, such as an MRI scan, an electronic prescription is configured to indicate that the IMD is authorized for the medical procedure that includes a disruptive energy field. The electronic prescription includes one or more designated bits within a storage element of the IMD. When the patient in which the IMD is implanted arrives for the medical procedure, a user (such as an MRI operator) interacts with a telemetry device to determine whether the electronic prescription is configured. Upon determining that the electronic prescription is configured, the IMD transitions into the exposure operating mode designed for operation in the disruptive energy field. In this manner, the electronic prescription confirms to the user that that the IMD has been checked for suitability for operation during the medical procedure.

Abstract: Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold.

Abstract: Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold.